179 related articles for article (PubMed ID: 1672809)
1. HLA class II antigens and DNA restriction fragment length polymorphism in myasthenia gravis in Japan.
Morita K; Moriuchi J; Inoko H; Tsuji K; Arimori S
Ann Neurol; 1991 Feb; 29(2):168-74. PubMed ID: 1672809
[TBL] [Abstract][Full Text] [Related]
2. HLA antigens and susceptibility to myasthenia gravis.
Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
[TBL] [Abstract][Full Text] [Related]
3. Clinical and immunological differences between early and late-onset myasthenia gravis in Japan.
Suzuki S; Utsugisawa K; Nagane Y; Satoh T; Kuwana M; Suzuki N
J Neuroimmunol; 2011 Jan; 230(1-2):148-52. PubMed ID: 21074862
[TBL] [Abstract][Full Text] [Related]
4. Identification of unrelated HLA-identical bone marrow donors: RFLP, oligotyping and PCR fingerprinting for HLA class II compared to MLC responses.
Mazzola G; el-Borai MH; Berrino M; Cornaglia M; Amoroso A
Bone Marrow Transplant; 1993; 11 Suppl 1():24-7. PubMed ID: 8095414
[TBL] [Abstract][Full Text] [Related]
5. A variant of childhood-onset myasthenia gravis: HLA typing and clinical characteristics in Japan.
Shinomiya N; Nomura Y; Segawa M
Clin Immunol; 2004 Feb; 110(2):154-8. PubMed ID: 15003812
[TBL] [Abstract][Full Text] [Related]
6. Crohn's disease in the Japanese is associated with the HLA-DRw53.
Kobayashi K; Atoh M; Yagita A; Konoeda Y; Inoko H; Ando A; Sekiguchi S
Exp Clin Immunogenet; 1990; 7(2):101-8. PubMed ID: 2322470
[TBL] [Abstract][Full Text] [Related]
7. HLA class I and class II polymorphisms in Saudi patients with myasthenia gravis.
Hajeer AH; Sawidan FA; Bohlega S; Saleh S; Sutton P; Shubaili A; Tahan AA; Al Jumah M
Int J Immunogenet; 2009 Jun; 36(3):169-72. PubMed ID: 19490212
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis and treatment of myasthenia gravis.
Arimori S
Tokai J Exp Clin Med; 1986; 11 Suppl():159-69. PubMed ID: 2454518
[TBL] [Abstract][Full Text] [Related]
9. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
10. [Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism].
Mao HT; Wang XB; Zhang L; Gu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):574-8. PubMed ID: 15583985
[TBL] [Abstract][Full Text] [Related]
11. HLA antigens in Japanese patients with myasthenia gravis.
Matsuki K; Juji T; Tokunaga K; Takamizawa M; Maeda H; Soda M; Nomura Y; Segawa M
J Clin Invest; 1990 Aug; 86(2):392-9. PubMed ID: 1974553
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR and -DQ genotyping in anti-GBM disease.
Dunckley H; Chapman JR; Burke J; Charlesworth J; Hayes J; Haywood E; Hutchison B; Ibels L; Kalowski S; Kincaid-Smith P
Dis Markers; 1991; 9(5):249-56. PubMed ID: 1686749
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity in myasthenia gravis: HLA phenotypes and autoantibody responses in ocular and generalized types.
Kida K; Hayashi M; Yamada I; Matsuda H; Yoshinaga J; Takami S; Yashiki S; Sonoda S
Ann Neurol; 1987 Mar; 21(3):274-8. PubMed ID: 3606034
[TBL] [Abstract][Full Text] [Related]
14. [HLA-DQ molecules associated with myasthenia gravis in Chinese patients].
Li X; Zhang KX; Fan YX; Chen XZ; Zuo J; Pan XH; Zhu DL; Geng ZC
Yi Chuan Xue Bao; 1999; 26(4):295-300. PubMed ID: 10593018
[TBL] [Abstract][Full Text] [Related]
15. [Acquired myasthenia gravis and HLA system].
Alberca R; Navarro A; Núñez-Roldán A; Wichmann I
Neurologia; 1987; 2(2):50-3. PubMed ID: 3274070
[No Abstract] [Full Text] [Related]
16. Different HLA DR-DQ associations in subgroups of idiopathic myasthenia gravis.
Carlsson B; Wallin J; Pirskanen R; Matell G; Smith CI
Immunogenetics; 1990; 31(5-6):285-90. PubMed ID: 1973409
[TBL] [Abstract][Full Text] [Related]
17. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and outcome of myasthenia gravis with and without thymoma after operation].
Wang RW; Jiang YG; Xue ZQ; Zhao YP; Ma Z
Zhonghua Wai Ke Za Zhi; 2004 May; 42(9):536-9. PubMed ID: 15196366
[TBL] [Abstract][Full Text] [Related]
19. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
Michelsen B; Lernmark A
J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
[TBL] [Abstract][Full Text] [Related]
20. Increased mast cell density and microvessel density in the thymus of patients with myasthenia gravis.
Raica M; Cîmpean AM; Encică S; Scridon T; Bârsan M
Rom J Morphol Embryol; 2007; 48(1):11-6. PubMed ID: 17502945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
